title: [Malignant pleural mesothelioma].
abstract: Malignant pleural mesothelioma (MMP) is a highly aggressive tumor arising of the                     pleural mesothelium. Asbestos exposure is the main factor involved in the                     pathogenesis of MMP and according to the late ban of this agent in 2005 the peak                     incidence in Europe is expected in the next twenty years. The highly aggressive                     behaviour of this tumor results in a poor prognosis with a mean overall survival                     between 7 and 9 months. Despite the progress made in diagnosis and therapy of                     this entity the optimal treatment remains a subject of debate. In this article                     we review the current state of treatment and diagnosis.
authors.affiliation: Abt. Thoraxchirurgie der Albert-Ludwigs Universität Freiburg.
authors.forename: T
authors.initials: T
authors.lastname: Ploenes
authors.forename: T
authors.initials: T
authors.lastname: Osei-Agyemang
authors.forename: U
authors.initials: U
authors.lastname: Nestle
authors.forename: C F
authors.initials: CF
authors.lastname: Waller
authors.forename: B
authors.initials: B
authors.lastname: Passlick
mesh_terms: D001194:Asbestos / Q000506:poisoning*; D006801:Humans; D008654:Mesothelioma / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*
chemical_list: D001194:Asbestos